Infusion of recombinant BDNF into Sprague-Dawley rat neocortex by an implanted osmotic minipump 2.5–14 days before, during, and for 2 days following MCAO reduced infarct volume as measured 2 days after stroke without affecting cerebral blood flow [13]. The gene discussed is BDNF; the disease is Stroke.